Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.840
-0.001 (-0.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $190.35 million as of December 20, 2024. Its market cap has decreased by -21.81% in one year.
Market Cap
190.35M
Enterprise Value
66.94M
1-Year Change
-21.81%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $190.35M, a decrease of -80.87%. That is a compound annual growth rate of -24.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 190.35M | -7.46% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | 701.04M | -26.45% |
| Dec 31, 2019 | 953.19M | -4.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 182.61M |
| EUDA Health Holdings | 181.22M |
| Inozyme Pharma | 180.51M |
| Accuray | 180.51M |
| Myomo | 179.96M |
| Nektar Therapeutics | 178.32M |
| Alector | 176.28M |
| BrainsWay | 176.20M |